{
  "resourceType" : "Bundle",
  "type" : "transaction",
  "entry" : [{
    "resource" : {
      "resourceType" : "MedicinalProductDefinition",
      "id" : "IMASTADA-400mg-Tablet-SE-IS-MedicinalProductDefinition",
      "extension" : [{
        "url" : "http://ema.europa.eu/fhir/extension/authorisedDoseForm",
        "valueCoding" : {
          "system" : "http://spor.ema.europa.eu/v1/lists/200000000004",
          "code" : "100000073665",
          "display" : "Film-coated tablet"
        }
      }],
      "identifier" : [{
        "system" : "http://ema.europa.eu/fhir/mpId",
        "value" : "SE-100000843-00050151"
      },
      {
        "system" : "http://ema.europa.eu/fhir/eurdId",
        "value" : "1725"
      }],
      "domain" : {
        "coding" : [{
          "system" : "http://spor.ema.europa.eu/v1/lists/100000000004",
          "code" : "100000000012",
          "display" : "Human use"
        }]
      },
      "status" : {
        "coding" : [{
          "system" : "http://spor.ema.europa.eu/v1/lists/200000005003",
          "code" : "200000005004",
          "display" : "Current"
        }]
      },
      "indication" : "Imatinib Stada är indicerat för behandling av  • vuxna och barn med nydiagnostiserad Philadelphiakromosom- (bcr-abl)-positiv (Ph+ ) kronisk myeloisk  leukemi (KML), för vilka benmärgstransplantation inte är en förstahandsbehandling • vuxna och barn med (Ph+ )-KML i kronisk fas efter terapisvikt med interferon alfa-behandling, eller i  accelererad fas eller blastkris • vuxna och barn med nyligen diagnosticerad Philadelphia-kromosom-positiv akut lymfoblastisk leukemi  (Ph+  ALL) tillsammans med kemoterapi • vuxna patienter med recidiverande eller refraktär Ph+  ALL som monoterapi • vuxna patienter med myelodysplastiska/myeloproliferativa sjukdomar (MDS/MPD) förenat med  rearrangemang av platelet-derived growth factor receptor (PDGFR)-genen • vuxna patienter med avancerat hypereosinofilt syndrom (HES) och/eller kronisk eosinofil leukemi (CEL)  med FIP1L1-PDGFRα-rearrangemang. Effekten av imatinib på utfallet av benmärgstransplantation har inte undersökts.  Imatinib Stada är indicerat för  • behandling av vuxna patienter med icke-resecerbara dermatofibrosarkoma protuberans (DFSP) och vuxna  patienter med återkommande och/eller metastaserande DFSP som är olämpliga att operera.  Hos vuxna och barn baseras effekten av imatinib på det sammantagna hematologiska och cytogenetiska  svaret och progressionsfri överlevnad vid KML, på hematologiskt och cytogenetiskt respons vid Ph+  ALL,  MDS/MPD, på hematologisk respons vid HES/CEL och på objektiv tumörrespons hos vuxna patienter vid  icke-resecerbara och/eller metastaserande DFSP. Erfarenheten av imatinib hos patienter med MDS/MPD  förenat med rearrangemang PDGFR-genen är mycket begränsat (se avsnitt 5.1). Förutom vid nyligen  diagnostiserad KML i kronisk fas finns det inga kontrollerade studier som visar på en klinisk nytta eller ökad  överlevnad för dessa sjukdomar.",
      "legalStatusOfSupply" : {
        "coding" : [{
          "system" : "http://spor.ema.europa.eu/v1/lists/100000072051",
          "code" : "100000072084",
          "display" : "Medicinal product subject to medical prescription"
        }]
      },
      "classification" : [{
        "coding" : [{
          "system" : "http://spor.ema.europa.eu/v1/lists/100000116677",
          "code" : "100000093533",
          "display" : "L01EA01"
        }]
      }],
      "name" : [{
        "productName" : "Imatinib STADA 400 mg Filmdragerad tablett"
      }]
    },
    "request" : {
      "method" : "PUT",
      "url" : "MedicinalProductDefinition/IMASTADA-400mg-Tablet-SE-IS-MedicinalProductDefinition"
    }
  },
  {
    "resource" : {
      "resourceType" : "RegulatedAuthorization",
      "id" : "IMASTADA-400mg-Tablet-SE-IS-RegulatedAuthorization",
      "identifier" : [{
        "system" : "http://ema.europa.eu/fhir/MarketingAuthorizationNumber",
        "value" : "50151"
      }],
      "subject" : [{
        "reference" : "MedicinalProductDefinition/IMASTADA-400mg-Tablet-SE-IS-MedicinalProductDefinition"
      }],
      "type" : {
        "coding" : [{
          "system" : "http://spor.ema.europa.eu/v1/lists/220000000060",
          "code" : "220000000061",
          "display" : "Marketing Authorisation"
        }]
      },
      "region" : [{
        "coding" : [{
          "system" : "http://spor.ema.europa.eu/v1/lists/100000000002",
          "code" : "100000000535",
          "display" : "Sweden"
        }]
      }],
      "status" : {
        "coding" : [{
          "system" : "http://spor.ema.europa.eu/v1/lists/100000072049",
          "code" : "100000072099",
          "display" : "Valid"
        }]
      },
      "statusDate" : "2015-11-12",
      "holder" : {
        "identifier" : {
          "system" : "https://spor.ema.europa.eu/v1/locations",
          "value" : "LOC-100001022"
        },
        "display" : "STADA Arzneimittel AG"
      },
      "case" : {
        "type" : {
          "coding" : [{
            "system" : "http://ema.europa.eu/fhir/authorisationDateType",
            "code" : "dateOfFirstAuthorisation",
            "display" : "First Authorisation"
          }]
        },
        "dateDateTime" : "2015-11-12"
      }
    },
    "request" : {
      "method" : "PUT",
      "url" : "RegulatedAuthorization/IMASTADA-400mg-Tablet-SE-IS-RegulatedAuthorization"
    }
  },
  {
    "resource" : {
      "resourceType" : "AdministrableProductDefinition",
      "id" : "IMASTADA-400mg-Tablet-SE-IS-AdministrableProductDefinition",
      "status" : "active",
      "formOf" : [{
        "reference" : "MedicinalProductDefinition/IMASTADA-400mg-Tablet-SE-IS-MedicinalProductDefinition"
      }],
      "administrableDoseForm" : {
        "coding" : [{
          "system" : "http://spor.ema.europa.eu/v1/lists/200000000004",
          "code" : "100000073665",
          "display" : "Film-coated tablet"
        }]
      },
      "producedFrom" : [{
        "reference" : "ManufacturedItemDefinition/IMASTADA-400mg-Tablet-SE-IS-ManufacturedItemDefinition"
      }],
      "routeOfAdministration" : [{
        "code" : {
          "coding" : [{
            "system" : "http://spor.ema.europa.eu/v1/lists/100000073345",
            "code" : "100000073619",
            "display" : "Oral use"
          }]
        }
      }]
    },
    "request" : {
      "method" : "PUT",
      "url" : "AdministrableProductDefinition/IMASTADA-400mg-Tablet-SE-IS-AdministrableProductDefinition"
    }
  },
  {
    "resource" : {
      "resourceType" : "PackagedProductDefinition",
      "id" : "IMASTADA-400mg-Tablet-SE-IS-PackagedProductDefinition",
      "extension" : [{
        "url" : "http://ema.europa.eu/fhir/extension/containedItemQuantity",
        "valueQuantity" : {
          "value" : 30,
          "unit" : "Tablet",
          "system" : "http://spor.ema.europa.eu/v1/lists/200000000014",
          "code" : "200000002152"
        }
      }],
      "packageFor" : [{
        "reference" : "MedicinalProductDefinition/IMASTADA-400mg-Tablet-SE-IS-MedicinalProductDefinition"
      }],
      "description" : "Burk, 30 tabletter",
      "_description" : {
        "extension" : [{
          "url" : "http://ema.europa.eu/fhir/extension/language",
          "valueCoding" : {
            "system" : "http://spor.ema.europa.eu/v1/lists/100000072057",
            "code" : "100000072288",
            "display" : "Swedish"
          }
        }]
      },
      "marketingStatus" : [{
        "country" : {
          "coding" : [{
            "system" : "http://spor.ema.europa.eu/v1/lists/100000000002",
            "code" : "100000000535",
            "display" : "Sweden"
          }]
        },
        "status" : {
          "coding" : [{
            "system" : "http://spor.ema.europa.eu/v1/lists/100000072052",
            "code" : "100000072083",
            "display" : "Marketed"
          }]
        },
        "dateRange" : {
          
        }
      }]
    },
    "request" : {
      "method" : "PUT",
      "url" : "PackagedProductDefinition/IMASTADA-400mg-Tablet-SE-IS-PackagedProductDefinition"
    }
  },
  {
    "resource" : {
      "resourceType" : "ManufacturedItemDefinition",
      "id" : "IMASTADA-400mg-Tablet-SE-IS-ManufacturedItemDefinition",
      "status" : "active",
      "manufacturedDoseForm" : {
        "coding" : [{
          "system" : "http://spor.ema.europa.eu/v1/lists/200000000004",
          "code" : "100000073665",
          "display" : "Film-coated tablet"
        }]
      },
      "unitOfPresentation" : {
        "coding" : [{
          "system" : "http://spor.ema.europa.eu/v1/lists/200000000014",
          "code" : "200000002152",
          "display" : "Tablet"
        }]
      }
    },
    "request" : {
      "method" : "PUT",
      "url" : "ManufacturedItemDefinition/IMASTADA-400mg-Tablet-SE-IS-ManufacturedItemDefinition"
    }
  },
  {
    "resource" : {
      "resourceType" : "Ingredient",
      "id" : "IMASTADA-400mg-Tablet-SE-IS-Ingredient",
      "status" : "active",
      "for" : [{
        "reference" : "MedicinalProductDefinition/IMASTADA-400mg-Tablet-SE-IS-MedicinalProductDefinition"
      },
      {
        "reference" : "ManufacturedItemDefinition/IMASTADA-400mg-Tablet-SE-IS-ManufacturedItemDefinition"
      },
      {
        "reference" : "AdministrableProductDefinition/IMASTADA-400mg-Tablet-SE-IS-AdministrableProductDefinition"
      }],
      "role" : {
        "coding" : [{
          "system" : "http://spor.ema.europa.eu/v1/lists/100000072050",
          "code" : "100000072072",
          "display" : "Active"
        }]
      },
      "substance" : {
        "code" : {
          "concept" : {
            "coding" : [{
              "system" : "http://spor.azure-api.net/sms/api/v2/SubstanceDefinition",
              "code" : "100000091825",
              "display" : "Imatinib mesilate"
            }]
          }
        },
        "strength" : [{
          "presentationRatio" : {
            "numerator" : {
              "value" : 477.88,
              "_comparator" : {
                "extension" : [{
                  "url" : "http://ema.europa.eu/fhir/extension/comparator",
                  "valueCoding" : {
                    "system" : "https://spor.ema.europa.eu/v1/lists/100000000008",
                    "code" : "100000000049",
                    "display" : "equal to"
                  }
                }]
              },
              "unit" : "milligram(s)",
              "system" : "http://spor.ema.europa.eu/v1/lists/100000110633",
              "code" : "100000110655"
            },
            "denominator" : {
              "value" : 1,
              "unit" : "unit(s)",
              "system" : "http://spor.ema.europa.eu/v1/lists/100000110633",
              "code" : "100000110756"
            }
          },
          "referenceStrength" : [{
            "substance" : {
              "concept" : {
                "coding" : [{
                  "system" : "https://spor.ema.europa.eu/v2/SubstanceDefinition",
                  "code" : "100000091894",
                  "display" : "Imatinib"
                }]
              }
            },
            "strengthRatio" : {
              "numerator" : {
                "value" : 400,
                "_comparator" : {
                  "extension" : [{
                    "url" : "http://ema.europa.eu/fhir/extension/comparator",
                    "valueCoding" : {
                      "system" : "https://spor.ema.europa.eu/v1/lists/100000000008",
                      "code" : "100000000049",
                      "display" : "equal to"
                    }
                  }]
                },
                "unit" : "milligram(s)",
                "system" : "http://spor.ema.europa.eu/v1/lists/100000110633",
                "code" : "100000110655"
              },
              "denominator" : {
                "value" : 1,
                "unit" : "unit(s)",
                "system" : "http://spor.ema.europa.eu/v1/lists/100000110633",
                "code" : "100000110756"
              }
            }
          }]
        }]
      }
    },
    "request" : {
      "method" : "PUT",
      "url" : "Ingredient/IMASTADA-400mg-Tablet-SE-IS-Ingredient"
    }
  }]
}